Type 2 Diabetes (T2D) Clinical Trials

Find Type 2 Diabetes (T2D) Clinical Trials Near You

Glucose Profiles in Women With Polycystic Ovary Syndrome

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Polycystic ovary syndrome is a very common condition that is associated with metabolic complications. Patients with polycystic ovary syndrome exhibit insulin resistance and are at greater risk to develop type 2 diabetes. This syndrome is heterogeneous, classified according to 4 phenotypes (A-D). It seems that certain phenotypes are less exposed to insulin resistance and metabolic complications. However, only a few studies have evaluated the glucose profile according to phenotype. New technologies now make it possible to monitor glucose levels continuously. The aim of this project is to evaluate glucose profile parameters using continuous glucose monitoring, and to compare these profiles according to different PCOS phenotypes.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:

• Age \> 18 years at inclusion criteria

• Patient with polycystic ovary syndrome, defined by the presence of at least 2/3 irregular menstrual cycles, clinical or biological hyperandrogenism, polycystic ovary morphology (pelvic ultrasound) or elevated AMH levels, after the exclusion of other disorders.

• Agreed to carry the FSL pro

• Signed informed consent

Locations
Other Locations
France
CHRU Amiens
RECRUITING
Salouël
Contact Information
Primary
Abdallah Al-Salameh, Pr
Al-Salameh.Abdallah@chu-amiens.fr
33+3.22.08.83.71
Time Frame
Start Date: 2026-01-06
Estimated Completion Date: 2027-07
Participants
Target number of participants: 80
Treatments
Experimental: Phenotype A
oligomenorrhoea or amenorrhoea + hyperandrogenism + polycystic ovary morphology or elevated AMH levels
Experimental: Phenotype B
hyperandrogenism + oligomenorrhoea or amenorrhoea
Experimental: Phenotype C
hyperandrogenism + polycystic ovary morphology or elevated AMH levels
Experimental: Phenotype D
oligomenorrhoea or amenorrhoea + polycystic ovary morphology or elevated AMH levels
Sponsors
Leads: Centre Hospitalier Universitaire, Amiens

This content was sourced from clinicaltrials.gov